SCHEMBL4390168

SCHEMBL4390168

CS(=O)(=O)c1nc2c(N)nc3cccnc3c2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 1/20 0.40
PRMT5 O14744 1/20 0.39
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
GLO1 Q04760 1/20 0.35
ATR Q13535 2/20 0.34
PRKDC P78527 1/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL212305 0.81 ALDH1A1 (0.42) CSNK2A1ALDH1A1HPGDTLR8TLR7
SCHEMBL842050 0.78 PRMT5 (0.42) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL204605 0.78 CSNK2A1 (0.39) CSNK2A1PRMT5ALDH1A1HPGDALOX15
SCHEMBL4390007 0.76 PRMT5 (0.41) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL5505830 0.75 PRMT5 (0.38) PRMT5ALDH1A1ALOX15HTTGLO1
SCHEMBL5264585 0.71 PRMT5 (0.38) PRMT5ALDH1A1HTTKDM4EMAPT
SCHEMBL1699171 0.70 ALDH1A1 (0.41) CSNK2A1CDK1ALDH1A1HPGDALOX15
Water SCHEMBL5259730 0.70 PRMT5 (0.37) PRMT5ALDH1A1HTTKDM4EMAPT
SCHEMBL2059193 0.69 TLR8 (0.43) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL311681 0.69 PRMT5 (0.42) PRMT5CDK1CDK2MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329721-B2 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 US disclosed
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS PFIZER INC. 2009-12-03 US disclosed
WO-2007106854-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZONAPHTHYRIDINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS IL2, IL4, IFNG CSNK2A1 1993/4885PRMT5 3717/4885CDK1 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.